Peter Mac’s Professor Mark Dawson’s has been recognised in the 2020 Prime Minister’s Prizes for Science for his pioneering research in the field of epigenetics and its impact on human health and disease.
Peter Mac researchers have been supported by the federal government’s MRFF Stem Cell Therapies Mission to investigate new stem cell-based therapies for diseases including leukemia and vision loss through macular degeneration.
Researchers from Peter Mac have discovered an innovative way to dampen severe inflammation, uncovering a potential new therapeutic approach for inflammatory and autoimmune conditions such as arthritis, psoriasis and liver disease, as well as some cancers.
Peter Mac’s Prof Mark Dawson has been named the 2020 recipient of the McCulloch & Till Award from the International Society for Experimental Haematology – the first time an Australian has received the honour.
Peter Mac scientists have found a way to target acute myeloid leukaemia (AML) at its source - a discovery that could yield a more effective treatment for this aggressive and often incurable blood cancer.
Prof Sarah-Jane Dawson, Prof Mark Dawson and Prof Karin Thursky have been awarded prestigious Dame Kate Campbell Fellowships from The University of Melbourne in recognition of outstanding research performance.
Congratulations to Professor Mark Dawson who was today announced as a recipient of Cancer Council Victoria's Sir Edward Dunlop Research Fellowship. The Fellowship provides $1.55M over five years to support Prof Dawson's pioneering research into epigenetic regulators, unlocking their potential to support new cancer treatments.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.